Teleflex Medical OEM has completed its acquisition by private equity firms Montagu and Kohlberg and rebranded as Ingenyx following its carve-out from Teleflex Incorporated (NYSE: TFX), according to a press release. The transaction was first announced on December 9, 2025.

Based in Plymouth, Minn., Ingenyx develops and manufactures custom-engineered interventional catheters and subassemblies, sutures, tubing, wiring, complex extrusion solutions, surgical fibers, and other medical device technologies. The company operates seven facilities across the United States, Ireland, and Mexico.

Greg Stotts, who previously served as chief executive officer of Teleflex Medical OEM, will continue in that role at Ingenyx. Matt Jennings, senior operating partner at Kohlberg, will serve as executive chairman of the board.

"Medical device companies face growing pressure to innovate faster while managing complexity, risk, and cost," Jennings said. "Ingenyx is uniquely positioned to meet that need by serving as a collaborative extension of our customers' teams, combining design for manufacturability methodology, and our proprietary intelligence databank with a deep understanding of the decisions that shape successful products."

The company stated it will expand its focus beyond traditional contract manufacturing to assist customers with product development, material selection, scalability, and lifecycle challenges.

Montagu manages €15 billion in assets under management. Kohlberg, founded in 1987 and based in Mount Kisco, New York, manages approximately $17 billion on behalf of investors globally.